Illumina (NASDAQ: ILMN) has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE